| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ELAN
Elanco Animal Health
|
Aug 12, 2026 | BUY |
Strong Buy
+39.8% avg upside
18 analysts
|
$34.00
50.96% Upside
|
+7.0% | · |
|
ALMR
Alamar Biosciences, Inc.
|
Aug 10, 2026 | HOLD |
Strong Buy
+1.3% avg upside
5 analysts
|
$31.00
5.92% Downside
|
· | · |
|
TXG
10x Genomics
|
Aug 07, 2026 | HOLD |
Buy
-29.1% avg upside
18 analysts
|
— | +7.8% | · |
|
CAI
Caris Life Sciences, Inc.
|
Aug 06, 2026 | BUY |
Strong Buy
+25.0% avg upside
20 analysts
|
— | +9.0% | · |
|
SDGR
Schrodinger
|
Aug 06, 2026 | BUY |
Strong Buy
+53.0% avg upside
14 analysts
|
— | -1.2% | · |
|
STVN
Stevanato Group
|
Aug 05, 2026 | BUY |
Strong Buy
+28.0% avg upside
13 analysts
|
— | +4.8% | · |
|
ILMN
Illumina
|
Aug 05, 2026 | SELL |
Buy
-8.8% avg upside
31 analysts
|
$140.00
27.30% Downside
|
+4.5% | · |
|
BRKR
Bruker
|
Aug 05, 2026 | BUY |
Buy
-1.8% avg upside
22 analysts
|
— | +10.0% | · |
|
WAT
Waters
|
Aug 04, 2026 | HOLD |
Strong Buy
-5.0% avg upside
31 analysts
|
$415.00
0.44% Upside
|
+4.4% | · |
|
MYGN
Myriad Genetics
|
Aug 03, 2026 | SELL |
Hold
+462.3% avg upside
24 analysts
|
$3.20
0.94% Upside
|
-7.0% | · |
|
TEM
Tempus AI, Inc. Class A
|
Aug 03, 2026 | HOLD |
Buy
+20.3% avg upside
21 analysts
|
$52.00
4.29% Downside
|
+13.1% | · |
|
DHR
Danaher
|
Aug 03, 2026 | BUY |
Strong Buy
+3.2% avg upside
45 analysts
|
$230.00
12.74% Upside
|
+3.6% | · |
|
GH
Guardant Health
|
Jul 31, 2026 | BUY |
Strong Buy
+2.2% avg upside
31 analysts
|
— | -2.9% | · |
|
MTD
Mettler-Toledo
|
Jul 31, 2026 | BUY |
Buy
-15.2% avg upside
18 analysts
|
— | +1.6% | · |
|
ICLR
Icon
|
Jul 30, 2026 | SELL |
Strong Buy
+12.5% avg upside
26 analysts
|
$160.00
4.41% Downside
|
+1.4% | · |
|
FTRE
Fortrea Holdings Inc.
|
Jul 30, 2026 | SELL |
Buy
+17.5% avg upside
12 analysts
|
— | +8.8% | · |
|
LH
Labcorp Holdings
|
Jul 30, 2026 | BUY |
Strong Buy
-15.9% avg upside
37 analysts
|
$360.00
11.50% Upside
|
+2.2% | · |
|
ALGN
Align Tech
|
Jul 30, 2026 | SELL |
Strong Buy
+69.0% avg upside
21 analysts
|
— | -4.6% | · |
|
PAHC
Phibro Animal Health
|
Jul 28, 2026 | SELL |
Hold
+9.2% avg upside
10 analysts
|
— | +5.5% | · |
|
ZTS
Zoetis
|
Jul 28, 2026 | HOLD |
Buy
+58.6% avg upside
23 analysts
|
— | -4.8% | · |
|
IQV
IQVIA Holdings
|
Jul 28, 2026 | BUY |
Strong Buy
+1.5% avg upside
39 analysts
|
$280.00
15.99% Upside
|
-2.6% | · |
|
DGX
Quest Diagnostics
|
Jul 24, 2026 | BUY |
Buy
-22.3% avg upside
34 analysts
|
$265.00
12.21% Upside
|
+4.3% | · |
|
WST
West Pharmaceutical Services
|
Jul 24, 2026 | BUY |
Strong Buy
+5.7% avg upside
18 analysts
|
$410.00
18.53% Upside
|
+5.5% | · |
|
TMO
Thermo Fisher
|
Jul 23, 2026 | BUY |
Strong Buy
+1.3% avg upside
38 analysts
|
$650.00
9.05% Upside
|
+2.8% | · |
|
EVO
Evotec AG
|
Jul 15, 2026 | SELL |
Buy
+315.9% avg upside
9 analysts
|
$2.40
18.88% Upside
|
+2.5% | · |
|
NEO
NeoGenomics
|
Jul 13, 2026 | HOLD |
Strong Buy
+4.7% avg upside
18 analysts
|
$16.00
2.34% Downside
|
+13.0% | · |
|
IDXX
Idexx Laboratories
|
Jul 07, 2026 | HOLD |
Buy
+27.4% avg upside
17 analysts
|
$660.00
16.33% Upside
|
+0.1% | · |
|
CRL
Charles River Labs
|
Jun 05, 2026 | BUY |
Strong Buy
-16.6% avg upside
35 analysts
|
— | +54.4% | · |
|
A
Agilent
|
Jun 02, 2026 | BUY |
Strong Buy
-0.0% avg upside
33 analysts
|
$155.00
3.84% Upside
|
+10.2% | · |
|
RVTY
Revvity
|
May 14, 2026 | HOLD |
Buy
-7.9% avg upside
23 analysts
|
— | +22.4% | · |
|
QGEN
Qiagen
|
May 13, 2026 | BUY |
Buy
-0.5% avg upside
24 analysts
|
$49.00
13.26% Upside
|
+32.5% | · |
|
AVTR
Avantor
|
Feb 11, 2026 | HOLD |
Buy
+11.7% avg upside
26 analysts
|
$11.00
20.66% Downside
|
+41.7% | · |
|
MRVI
Maravai Lifesciences Holdings
|
Mar 03, 2025 | BUY |
Strong Buy
+148.4% avg upside
17 analysts
|
$8.00
38.39% Upside
|
+22.2% | · |
|
CERT
Certara
|
Feb 27, 2025 | BUY |
Buy
+61.3% avg upside
22 analysts
|
$17.00
108.52% Upside
|
-42.9% | · |
|
DNA
Ginkgo Bioworks Holdings
|
Jul 18, 2024 | SELL |
Strong Sell
-2.6% avg upside
6 analysts
|
$10.00
38.20% Upside
|
+16.4% | · |
|
SDCCQ
SmileDirectClub
|
Aug 08, 2023 | SELL |
Sell
+114399900.0% avg upside
10 analysts
|
$0.40
3999900.07% Upside
|
· | · |
|
ABSI
AbSci
|
Apr 24, 2023 | SELL |
Strong Buy
+28.7% avg upside
18 analysts
|
$2.40
74.61% Downside
|
-192.3% | · |
|
RXRX
Recursion Pharmaceuticals
|
Apr 18, 2022 | HOLD |
Buy
+139.9% avg upside
12 analysts
|
$10.00
202.07% Upside
|
-9.0% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.